Message from the chair

It gives me great pleasure as the inaugural Chairman of the Asia-Pacific Gynecologic Oncology Trials Group (APGOT) to welcome you to our official website. 

david.jpgAPGOT was formed in 2019 with the idea of consolidating collaborations among a cadre of highly-experienced and like-minded clinical investigators from well-established, country-specific clinical research networks that are committed to performing gynecological cancer focused clinical trials and training the next generation of clinician investigators. The consortium was initially comprised of the Korean Gynecologic Oncology Group (KGOG), the Gynecologic Cancer Group Singapore (GCGS) and the Australian-New Zealand Gynecologic Oncology Group (ANZGOG) and GOTIC (North Kanto Gynecologic Cancer Clinical Trials Consortium) from Japan.

The utopian vision of personalised medicine in oncology is to ensure that the right patient gets the right treatment 100% of the time, thus enhancing the benefit to risk ratio of treatment, resulting in increased quality of life, reduced morbidity, improved survival and better cost-effectiveness of cancer care for the patient.  The spectrum and development of molecularly-targeted anti-cancer treatments is rapidly expanding.  In the context of gynecological cancer, there is an urgent need to better characterise and understand the molecular features that the drive the development and progression of these cancers, and to identify the optimal therapeutic strategies for patients regardless of socio-economic and ethnic backgrounds. Ultimately, it is our vision to advance research and development of therapeutics and diagnostics in gynaecological cancers through APGOT by facilitating the conduct of investigator-initiated and pharma-sponsored studies testing novel therapeutic and diagnostic strategies across a large and ethnically diverse patient population in the Asia-Pacific Region. To this end, we will also aim to continually expand our network of research collaborators from other countries within the Asia-Pacific Region and beyond as well.

Our Mission:

The APGOT mission is to provide an international platform for collaborative efforts to develop better treatments for patients with gynecological cancers, and to enable good translational science to impact positively on patient outcomes, thus improving health outcomes for all women globally.

We look forward to working with you to achieve this mission!

Best regards,

David SP Tan